ATIVAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ativan, and what generic alternatives are available?
Ativan is a drug marketed by Hikma and Bausch and is included in two NDAs.
The generic ingredient in ATIVAN is lorazepam. There are eleven drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the lorazepam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ativan
A generic version of ATIVAN was approved as lorazepam by SANDOZ on April 21st, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ATIVAN?
- What are the global sales for ATIVAN?
- What is Average Wholesale Price for ATIVAN?
Summary for ATIVAN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 50 |
Clinical Trials: | 44 |
Patent Applications: | 4,332 |
Drug Prices: | Drug price information for ATIVAN |
What excipients (inactive ingredients) are in ATIVAN? | ATIVAN excipients list |
DailyMed Link: | ATIVAN at DailyMed |
Recent Clinical Trials for ATIVAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
California Institute of Technology | Phase 4 |
Laureate Institute for Brain Research, Inc. | Phase 4 |
Temple University | Phase 4 |
Pharmacology for ATIVAN
Drug Class | Benzodiazepine |
US Patents and Regulatory Information for ATIVAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | ATIVAN | lorazepam | TABLET;ORAL | 017794-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | ATIVAN | lorazepam | TABLET;ORAL | 017794-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Bausch | ATIVAN | lorazepam | TABLET;ORAL | 017794-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ATIVAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ATIVAN
See the table below for patents covering ATIVAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Belgium | 794224 | ⤷ Sign Up | |
Australia | 5024072 | ⤷ Sign Up | |
Ireland | 38298 | PARENTERAL BENZODIAZEPINE COMPOSITIONS | ⤷ Sign Up |
France | 2181679 | ⤷ Sign Up | |
United Kingdom | 1345510 | ⤷ Sign Up | |
Australia | 461715 | ⤷ Sign Up | |
Netherlands | 7300694 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |